General methods and instrumentation for non-natural amino acids synthesis: All reactions were carried out under nitrogen atmosphere unless otherwise specified. When dry solvents were necessary (dichloromethane, diethyl ether and tetrahydrofuran), the Innovative Technology Inc. Puresolv purification system Solvent Purification System (SPS) were used.
Other dry solvents were purchased from Sigma-Aldrich and used without further purification.
All experiments were monitored by analytical thin layer chromatography (TLC) performed on silica gel TLC-aluminum sheets (Merck 60 F254). Chromatographic purifications were carried out using a CombiflashR (Teledyne Isco) automated chromatography system unless otherwise stated. Silica gel RediHepR columns were used. The elution was carried out using hexanes/EtOAc gradients.
NMR spectra of small molecules (non peptidic) were recorded at room temperature on a Varian Mercury 400. 1H NMR and 13C NMR spectra were referenced to residual solvent peaks. 19F NMR spectra were referenced by the spectrometer without external reference.
Signal multiplicities in the 13C spectra have been assigned by DEPT (Direct Enhancement by Polarization Transfer) and HSQC (Hetero-nuclear Single Quantum Correlation) experiments and are described as C (quaternary), CH (tertiary), CH2 (secondary) and CH3 (primary). The following abbreviations were used to define the multiplicities: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. The coupling constants (J) are measured in hertz (Hz).
Melting points were measured using DSC 822e Mettler-Toledo apparatus. HRMS experiments were carried out in The Mass Spectrometry Core Facility located in the Institute for Research in Biomedicine of the using NanoESI techniques. CHNS elemental analyses have all been determined by the Unitat de Tècniques Separitives i Síntesi de Pèptids (The Separation Techniques and Peptide Synthesis Unit) located at the Barcelona Science Park. All IR spectrums have been obtained using a Thermo Nicolet Nexus FT-IR Fourier transform spectrometer. The samples were prepared by either dissolution in solvent and subsequent formation of a film on a NaCl disc by evaporation of the prepared solution or by the preparation of a KBr disc.
Optical rotations were measured at room temperature (25°C) using a Jasco P-2000 iRM-800 polarimeter. A cell with a length of 1 dm and a volume of 1 mL has been used. The concentration is expressed in the form g/100 mL. A sodium lamp with a wavelength of 589 nm has been employed. To a two-neck 100-mL round-bottom flask fitted with a mechanical stirrer and a condenser, under N2 atmosphere, was added N-acetylglycine (8.2 g, 70 mmol), Ac2O (18 mL, 175 mmol), NaOAc (5.8 g, 70 mmol) and 3,5-difluorobenzaldehyde (10 g, 70 mmol). The mixture was stirred for 2 h at 100 ºC to provide a light brown solution.
The crude was allowed to cool to room temperature and a stirrable paste was formed. Then, it was cooled to 0 C and cold water (60 mL) was added. The mixture was stirred 10 min.
Filtration, washing the collected solid with cold water (3x15 mL) and drying at 50 C in vacuo provided 14.1 g (90% yield) of the titled compound (1) as a light brown powder, which was used in the next reaction without further purification. (m, 2H, Ar), 7.0 (s, 1H, CH), 6.9 ((tt, J = 9 and 2 Hz, 1H), 1H, Ar), 2.4 (s, 3H, CH3) ppm.
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C-NMR (100 MHz, CDCl3):  167.6 (CO), 167.0 (C, Az), 162.9 ((dd, JF = 249, 13 Hz) 2 C, Cε Ar), 135.8 ((t, JF = 10 Hz) C, Ar), 134.6 (s, C, Az), 128.1 ((t, JF = 3 Hz) CH, Cβ), 114.5 (m, 2 CH, Cδ Ar), 106.7 ((t, JF = 26 Hz) 2 CH, Cz Ar), 15.7 (CH3) ppm. (10 g, 45 mmol, 1 eq) was dissolved in anhydrous MeOH (133 mL) in a two-neck 250-mL round-bottom flask fitted with a mechanical stirrer and a condenser, and under N2 atmosphere. MeONa (3.8 g, 49 mmol, 1.1 eq) was added dropwise, and the reaction mixture was stirred for 2 h at 70 ºC. The crude was allowed to cool to room temperature and the solvent was evaporated under reduced pressure.
The crude mixture was redissolved, neutralized with HCl and extracted with AcOEt. The combined extracts were washed with brine solution and dried over MgSO4. After filtration of MgSO4, the solvent was removed under vacuum and the brown colored residue was purified by silica gel flash chromatography to give pure 6.9 g (27 mmol, 65 % yield) of the titled product (2) as a white solid. A high pressure reaction vessel was charged with a mixture of (Z)-methyl 2-acetamido-3-(3,5-difluorophenyl)acrylate (2) (7.35 g, 32. 
L-3-(3,5-difluorophenyl)-alanine hydrochloride, (4)
A mixture of (S)-methyl 2-acetamido-3- (3,5-difluorophenyl) propanoate (3) (7.0 g, 27.2 mmol) and concentrated HCl (36 mL) was subjected to reflux conditions for 30 minutes. Then, 77 mL of HCl (6M) was added, and the reaction was stirred for 6 h at the same temperature. After the reaction vessel spontaneously get the room temperature, the solvent is evaporated at reduced pressure and the white solid obtained was filtrated, washed and dried to quantitatively afford the hydrochloric salt of the L-3-(3,5-difluorophenyl)alanine (4). Hz, 1H, CH2β) ppm. 
N-Fmoc-L-3-(3,5-difluorophenyl)-alanine, (5)
The L-3-(3,5-difluorophenyl)-alanine hydrochloride (5) (6.2 g, 26.2 mmol) was suspended in 66 mL of an aqueous solution of Na2CO3 (7.6 g, 72 mmol). The mixture was cooled to 0 ºC and a solution of FmocOSu (12.1 g, 36 mmol) in acetone (66 mL) was slowly added. The resulting mixture was allowed to warm to room temperature and stirred for 20h. Then, 20mL of water was added and the reaction mixture was extracted with ethyl acetate. The organic layer was back extracted with water, and the combined aqueous layers were washed with AcOEt, acidified to a pH of 1 with aqueous HCl and extracted with AcOEt.
The combined organic layers were dried and concentrated in vacuo to give 9.9 g of N-Fmoc-L-3-(3,5-difluorophenyl)-alanine V as a white solid (89% yield, 99% e.e.). The resulting product can be purified by flash chromatography if necessary using mixtures AcOEt/Hexanes (1% AcOH).
[α]D= -139.1 (c 0.50, CHCl3 General procedures for peptide synthesis: All peptides were synthesized by SPPS using the Fmoc/tBu strategy. Solid-phase peptide syntheses were performed in polypropylene syringes provided with a porous polyethylene filter and attached to a vacuum manifold. The syringes volumes used were 5, 10 or 20 mL, depending on the scale of the synthesis. Reagents and solvents were added to the syringe containing the resin and the mixture was stirred in an orbital shaker. After each treatment, the solvent and the excess of reagents were removed by filtration through the vacuum system. After each synthetic step, the resin was washed with DCM (3 x 1 min), DMF (3 x 1 min) and DCM (3 x 1 min) unless otherwise specified. Anal. Biochem. 1970, 34, 595-598. pyridine (100 mL). Both solutions were stirred for 45 min with 40 g of Amberlite MB-3 ion exchange resin, filtered and combined.
-Preparation of reagent solution B: Ninhydryn (2.5 g) was dissolved in EtOH (50 mL).
The resulting solution was kept in a flask protected from light.
All commercial amino acid were purchased from Senn Chemicals. The 3-mesityl alanine amino acid (Fmoc-L-Msa-OH) was synthesized as we previously reported. [L-Dfp7,D-Trp8]-SRIF (2): Somatostatin analog 2 was synthesized following the general procedure from 0.20 g of 2-Cl-Trt resin (0.8 mmol/g) and using Fmoc-L-Dfp-OH, affording 0.11 g in 53% yield (99% purity after purification [D-Trp8,L-Dfp11]-SRIF (3): Somatostatin analog 3 was synthesized following the general procedure from 0.20 g of 2-Cl-Trt resin (0.8 mmol/g) and using Fmoc-L-Dfp-OH, affording 0.14 g in 67% yield (99% purity after purification mM Tris-HCl (pH 7.5) and dried, after which scintillator sheets were melted onto the filter and the bound radioactivity was analyzed in a liquid scintillation counter (microβ plus, Wallac). Specific binding was defined as the total 125 I-Tyr11-SRIF binding minus the amount bound in the presence of 1000 nM SRIF (non-specific binding).
